Pulse Biosciences (PLSE) Accounts Payables (2015 - 2025)

Pulse Biosciences' Accounts Payables history runs 11 years deep, the most recent figure standing at $2.8 million for Q4 2025.

• In Q4 2025, Accounts Payables rose 65.99% year-over-year to $2.8 million; the TTM figure through Dec 2025 stood at $2.8 million (up 65.99% YoY), while the FY2025 annual figure was $2.8 million, up 65.99% from the prior year.
• Accounts Payables was $2.8 million for Q4 2025 at Pulse Biosciences, down from $3.0 million in the prior quarter.
• In the past five years, Accounts Payables ranged from a high of $3.5 million in Q1 2022 to a low of $1.4 million in Q3 2023.
• Historically, Accounts Payables has averaged $2.2 million across 5 years, with a median of $2.0 million in 2022.
• The sharpest annual moves came in 2021 and 2023: Accounts Payables surged 89.59% in 2021, then tumbled 38.04% in 2023.
• A 5-year view of Accounts Payables shows it stood at $1.8 million in 2021, then retreated by 14.32% to $1.6 million in 2022, then rose by 16.72% to $1.8 million in 2023, then decreased by 8.88% to $1.7 million in 2024, then jumped by 65.99% to $2.8 million in 2025.
• The last three Accounts Payables figures came in at $2.8 million (Q4 2025), $3.0 million (Q3 2025), and $2.7 million (Q2 2025), per Business Quant data.